Proteogenomic mapping sets stage for precision medicine
Nat Metab
.
2023 Mar;5(3):366-367.
doi: 10.1038/s42255-023-00759-1.
Authors
Daniel E Coral
1
,
Paul W Franks
2
3
4
Affiliations
1
Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Malmo, Sweden.
2
Lund University Diabetes Centre, Department of Clinical Sciences, Lund University, Malmo, Sweden. paul.franks@med.lu.se.
3
Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK. paul.franks@med.lu.se.
4
Harvard T.H. Chan School of Public Health, Boston, MA, USA. paul.franks@med.lu.se.
PMID:
36823472
DOI:
10.1038/s42255-023-00759-1
No abstract available
Publication types
Comment
MeSH terms
Precision Medicine
Proteogenomics*
Tandem Mass Spectrometry